13F

Stock

Neurocrine Biosciences Inc

NBIX · held by 6 managers

Reported value

$28.2M

Holders

6

+1 new · −0 exited

Holders’ est. mark

−$7.25M

Price effect on 3 books still in the name

Largest holder

$20.8M

BARCLAYS PLC

Holder count by quarter

Who holds it

Notable only
InvestorSharesValueEst. markChange
BARCLAYS PLC653.3K$20.8M−$7.71MAdded$2.23M
Swiss Life Asset Management Ltd25.8K$2.9M$82.5KAdded$2.47M
DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main20.5K$2.3M$372.7KCut−$1.5M
ONTARIO TEACHERS PENSION PLAN BOARD20.1K$2.26MHeld
Leonteq Securities AG211$23.7KNew

Positions as of Q3 2023. 13F filings arrive up to 45 days after quarter-end and omit shorts. Values are quarter-end marks, as filed. Estimated mark is the price effect on shares still held — not realized P&L or investment advice.